MedX Health Corp (MDX) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.069x

Based on the latest financial reports, MedX Health Corp (MDX) has a cash flow conversion efficiency ratio of 0.069x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-687.65K ≈ $-497.43K USD) by net assets (CA$-10.02 Million ≈ $-7.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see MedX Health Corp (MDX) market capitalisation for the company's overall valuation and market capitalisation.

MedX Health Corp - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how MedX Health Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.

MedX Health Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of MedX Health Corp ranked by their cash flow conversion efficiency. See MedX Health Corp debt service capacity to evaluate how effectively operating cash flow covers total debt obligations.

Company Cash Flow Conversion Efficiency
Blue Star Helium Ltd
AU:BNL
-0.252x
Grand Pacific Petrochemical Corp Pref
TW:1312A
-0.026x
Alarum Technologies Ltd.
NASDAQ:ALAR
-0.034x
Minbos Resources Ltd
AU:MNB
-0.118x
Vinpai SAS
PA:ALVIN
-0.313x
Park Ha Biological Technology Co., Ltd.
NASDAQ:PHH
-12.940x
Ornapaper Bhd
KLSE:5065
0.003x
Highcom Ltd
AU:HCL
-0.238x

Annual Cash Flow Conversion Efficiency for MedX Health Corp (2013–2024)

The table below shows the annual cash flow conversion efficiency of MedX Health Corp from 2013 to 2024. View MedX Health Corp (MDX) share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CA$-8.52 Million
≈ $-6.17 Million
CA$-2.51 Million
≈ $-1.82 Million
0.295x -38.53%
2023-12-31 CA$-7.14 Million
≈ $-5.17 Million
CA$-3.42 Million
≈ $-2.48 Million
0.479x +21.14%
2022-12-31 CA$-7.08 Million
≈ $-5.12 Million
CA$-2.80 Million
≈ $-2.03 Million
0.396x -68.21%
2021-12-31 CA$-3.63 Million
≈ $-2.63 Million
CA$-4.52 Million
≈ $-3.27 Million
1.244x -11.46%
2020-12-31 CA$-2.07 Million
≈ $-1.50 Million
CA$-2.91 Million
≈ $-2.10 Million
1.405x +204.09%
2019-12-31 CA$-2.87 Million
≈ $-2.07 Million
CA$-1.32 Million
≈ $-958.33K
0.462x -72.62%
2018-12-31 CA$-1.54 Million
≈ $-1.12 Million
CA$-2.61 Million
≈ $-1.89 Million
1.688x +72.37%
2017-12-31 CA$-1.50 Million
≈ $-1.09 Million
CA$-1.47 Million
≈ $-1.06 Million
0.979x +34.25%
2016-12-31 CA$-1.83 Million
≈ $-1.32 Million
CA$-1.33 Million
≈ $-963.12K
0.729x +225.13%
2015-12-31 CA$-2.39 Million
≈ $-1.73 Million
CA$-536.53K
≈ $-388.12K
0.224x -41.31%
2014-12-31 CA$-2.26 Million
≈ $-1.64 Million
CA$-864.08K
≈ $-625.06K
0.382x +814.58%
2013-12-31 CA$-3.40 Million
≈ $-2.46 Million
CA$-141.94K
≈ $-102.68K
0.042x --

About MedX Health Corp

V:MDX Canada Medical Devices
Market Cap
$13.05 Million
CA$18.04 Million CAD
Market Cap Rank
#26474 Global
#1069 in Canada
Share Price
CA$0.06
Change (1 day)
+10.00%
52-Week Range
CA$0.05 - CA$0.07
All Time High
CA$0.30
About

MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED … Read more